Drugs / OSP:rTTHc CCV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07509047 | Jan 2026 → Mar 2027 expected | — | International Vaccine Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OSP:rTTHc CCV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07509047 ↗ |
| Modality | Vaccine | “cholera conjugate vaccine” NCT07509047 ↗ |
| Route | Intramuscular | “CCV 25 μg (with or without alum) and placebo are administered by intramuscular (IM) injection.” NCT07509047 ↗ |